Showing results (121-130 of 199) with videos related to
Sort By:
Pageof 20
Oncotarget|May 30, 2013
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1Ariel Bier, Nis Giladi, Noan Kronfeld, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaL Burt Nabors, Tom Mikkelsen, Steven S Rosenfeld, et al.Radiation Research|May 27, 2015
MRI-Tracked Tumor Vascular Changes in the Hours after Single-Fraction IrradiationStephen L Brown, Tavarekere N Nagaraja, Madhava P Aryal, et al.Radiology|March 21, 2014
Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumorRajan Jain, Laila M Poisson, David Gutman, et al.Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.Journal of Neuro-Oncology|June 15, 2006
Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM)Jessica M Grunda, L Burton Nabors, Cheryl A Palmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.Cell Cycle (Georgetown, Tex.)|January 26, 2012
Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomasNorman L Lehman, James P O'Donnell, Lisa J Whiteley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent GlioblastomaHenry S Friedman, Michael D Prados, Patrick Y Wen, et al.The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.Pageof 20